Skip to main content
Caplight Logo









AFX Medical

AFX Medical

Private
MontrealHealthcare & Life Scienceshttps://afxmedical.com

Last Round

Grant

May 10, 2022

Total Funding Raised

$127,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AFX Medical is a software company that develops AI-powered software designed to enhance the accuracy and speed of neuro-oncology imaging for brain tumor detection.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

brain metastases detectionmedical imaging AIradiology AIneuro-oncology softwarePACS integrationclinical decision supportlesion trackingtreatment monitoring softwareMRI analysiscancer diagnosis softwarecomputer visiondeep learning

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AFX Medical Comparables

Compare AFX Medical with similar companies based on industry and business-model similarity.

AFX Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neosoma, Inc.
92%
Robovision
78%
Cortechs.ai
77%

AFX Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 10, 2022
AcceleratorSep 10, 2018

Key People

Founding team and executive leadership

Simon Ducharme

Co-Founder And Chief Medical Officer

Founding Team

David Roberge

Chief Executive Officer

Executive Team

Gabriel Chartrand

CTO

Executive Team

AFX Medical Investors

Notable investors and investment history

AFX Medical investors
InvestorRounds
TechstarsAccelerator
Real VenturesAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors grew 388% MoM, reaching 834.

  • Mar 1, 2026

    Monthly visitors grew 336% MoM, from 278 to 1.2K.

AFX Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AFX Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AFX Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal
Employee Range4
Year Founded2018
Last FundingMay 10, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?